`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`—————
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`—————
`
`SLAYBACK PHARMA LLC,
`Petitioner,
`
`v.
`
`EYE THERAPIES, LLC,
`Patent Owner.
`
`—————
`
`Case No.: IPR2022-00142
`
`U.S. Patent No.: 8,293,742
`
`—————
`
`PETITIONER’S UPDATED MANDATORY NOTICES
`PURSUANT TO 37 C.F.R. § 42.8
`
`1
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.8, Petitioner Slayback Pharma LLC hereby
`
`submits the following updated mandatory notices.
`
`I.
`
`REAL PARTY-IN-INTEREST (37 C.F.R. § 42.8(b)(1)) (Updated)
`
`Petitioner identifies Dr. Reddy’s Laboratories S.A. and Dr. Reddy’s
`
`Laboratories, Inc. as real parties-in-interest.
`
`II.
`
`RELATED MATTERS (Updated)
`
`In parallel with this proceeding, Petitioner submitted a Petition for IPR of
`
`U.S. Patent No. 9,259,425 (“the ‘425 patent”) (IPR2022-00146), which was
`
`instituted and placed on the same schedule as this proceeding.
`
`Except as detailed above, to the best of Petitioner’s knowledge, the ‘425
`
`patent and the ‘742 patent have not been the subject of any prior Petition for IPR.
`
`Patent Owner has asserted the ‘742 patent in the following litigations:
`
`Bausch & Lomb Inc. et al. v. Slayback Pharma LLC et al., 3:21-cv-16766 (D.N.J.),
`
`and Bausch & Lomb, Inc. et al. v. Lupin Limited et al., 3:22-cv-00534 (D.N.J.).
`
`To the best of Petitioner’s knowledge, the ‘742 patent has not been asserted
`
`in any other litigations.
`
`III.
`
`IDENTIFICATION OF COUNSEL AND SERVICE
`INFORMATION (Updated)
`
`Lead Counsel: Linnea P. Cipriano (Reg. No. 67,729; Tel. 212-813-
`
`8800, Cell 443-235-1739; lcipriano@goodwinlaw.com) attorney at
`
`Goodwin Procter LLP, 620 Eighth Avenue, New York, NY 10018.
`
`
`
`2
`
`
`
`
`
`Backup Counsel: Louis H. Weinstein (Reg. No. 45,205; Tel.
`
`973.966.3236; Cell 201-463-1964; lweinstein@windelsmarx.com),
`
`attorney at Windels Marx Lane & Mittendorf, LLP, 1 Giralda Farms,
`
`Madison, NJ 07940.
`
`Patrick G. Pollard (Reg. No. 64,084; Tel. 973.966.3249; Cell 201-
`
`259-1679; ppollard@windelsmarx.com), attorney at Windels Marx Lane &
`
`Mittendorf, LLP, 1 Giralda Farms, Madison, NJ 07940.
`
`Robert Frederickson III (Pro hac vice application to be filed, Tel.
`
`(617) 570-1947; Cell 973-229-6925; rfrederickson@goodwinlaw.com),
`
`attorney at Goodwin Procter LLP, 100 Northern Ave, Boston, MA 02210.
`
`IV.
`
`SERVICE INFORMATION (Updated)
`
`Please direct all correspondence to counsel at the contact information above.
`
`Petitioner consents to service by electronic mail at
`
`DG-BrimonidineIPRs@goodwinlaw.com, lweinstein@windelsmarx.com, and
`
`ppollard@windelsmarx.com.
`
`
`
`
`
`
`
`August 1, 2022
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/s/ Louis H. Weinstein
`Louis H. Weinstein
`Reg. No. 45,205
`Counsel for Petitioner Slayback
`Pharma LLC
`
`
`
`3
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing PETITIONER’S
`
`UPDATED MANDATORY NOTICES TO 37 C.F.R. § 42.8 was served on August
`
`1, 2022, by electronic mail to:
`
`
`
`Bryan Diner
`
`bryan.diner@finnegan.com
`
`Justin.hasford@finnegan.com
`
`Justin Hasford
`
`Caitlin O’Connell caitlin.oconnell@finnegan.com
`
` Christina Yang christina.yang@finnegan.com
`
`
`August 1, 2022
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ Louis H. Weinstein
`Louis H. Weinstein
`Reg. No. 45,205
`Counsel for Petitioner Slayback
`Pharma LLC
`
`
`
`
`
`4
`
`